medigraphic.com

2011, Number 4

<< Back Next >>

Rev Hematol Mex 2011; 12 (4)

Potential therapeutic utility of stem cells from the amniotic membrane

Insausti CL, Blanquer M, Majado MJ, Insausti A, Moraleda JM

Language: Spanish
References: 75
Page: 276-286
PDF size: 127.17 Kb.


ABSTRACT

Since the first studies on amniotic-derived stem cells were published, much knowledge has been gained regarding the characteristics, handling methods and potential of these cells. A lot of preclinical evidence suggests that human amniotic derived cells may be useful for treating a range of pathologic conditions, joining the list of significant contributors to regenerative medicine. Whether the beneficial effects of amniotic derived cells are due to differentiation of the transplanted cells themselves or to paracrine actions on the surrounding host tissue in order to reduce inflammation and promote regeneration remains to be fully elucidated. In making new cell therapy-based strategies a clinical reality, it is fundamental a close collaboration between basic scientists and clinicians.


REFERENCES

  1. Bourne G. The Foetal Membranes. A Review of the Anatomy of Normal Amnion and Chorion and Some Aspects of Their Function. Postgrad Med J 1962;38:193-201.

  2. Benirschke K., Kaufman P. Anatomy and Pathology of the placental membranes. In: Pathology of the Human Placenta. 4th ed. New York: Springer, 2000;281-334.

  3. Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, et al. Properties of the amniotic membrane for potential use in tissue engineering. European Cells and materials 2008; 15:88-99.

  4. Dobreva MP, Pereira PM, Deprest J, Zwijsen A. On the origin of amniotic stem cells: of mice and men. Int J Dev Biol 2010;54:761-777.

  5. Miki T, Lehmann T, Cai H, Stolz D, Strom S. Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005;23:1549-1559.

  6. Miki T, Strom SC. Amnion derived pluripotent-multipotent stem cells. Stem Cell Rev 2006;2:133-142.

  7. Ilancheran S, Michalska A, Peh G, Wallace EM, et al. Stem cell derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 2007;77(3):577-588.

  8. Insausti CL, Blanquer M, Bleda P, Iniesta P, et al. The amniotic membrane as a source of stem cells. Histol Histopathol 2010;25:91-98.

  9. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct 2004;29:73-83.

  10. Niknejad H, Peirovi H, Ahmadiani A, Ghanavi J, Jorjani M. Differentiation factors that influence neuronal markers expression in vitro from human amniotic epithelial cells. European Cells and Materials 2010;19:22-29.

  11. Bilic G, Zeisberger SM, Mallik AS, Zimmermann R, Zisch AH. Comparative Characterization of Cultured Human Term Amnion Epithelial and Mesenchymal Stromal Cells for Application in Cell Therapy. Cell Transplantation 2008;17:955-968.

  12. Parolini O, Soncini M. Human Placenta: a source of progenitor/stem cells? J Reproduktionsmed Endokrinol 2006;3:117-126.

  13. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, et al. Placental mesenchymal stem cells as potential autologous graft for pre and perinatal neuroregeneration. Am J Obstet Gynecol 2006;194:664-673.

  14. Parolini O, Alviano F, Bergwerf I, Boraschi D, et al. Toward cell therapy using placenta-derived cells: Disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem cells and development 2010;19:143-154.

  15. Alviano F, Fossati V, Marchionni C, Arpinati M, et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC developmental. Biology 2007; 7:1-14.

  16. Soncini M, Vertua E, Gibelli L, Zorzi F, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 2007; 1:296-305.

  17. Kim J, Mi Kang H, Kim H, Ran Kim M, et al. Ex vivo characteristics of human amniotic membrane- derived stem cells. Cloning and stem cells 2007;9:581-594.

  18. Wei JP, Nawata M, Wakitani S, Kametani K, et al. Human amniotic mesenchymal cells differentiate into chondrocytes. Cloning and Stem Cells 2009;11:19-25.

  19. Parolini O, Alviano F, Bagnara G, Bilic G, et al. Concise Review: Isolation and characterization of cells from human term placenta: outcome of the First International Workshop on Placenta Derived Stem Cells. Stem Cells 2008;26:300-311.

  20. Whittle WL, Gibb W, Challis JRG. Characterization of human amnion epithelial and mesenchymal cells: the cellular expression, activity and glucocorticoid regulation of prostaglandin output. Placenta 2000;21:394-401.

  21. Li H, Niederkorn J, Neelam S, Mayhew E, et al. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 2005; 46:900-907.

  22. Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, et al. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res 2000;20:173-177.

  23. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of anti-angiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000;19:348-352.

  24. Solomon A, Rosenblatt M, Monroy D, Ji Z, et al. Suppression of interleukin 1 (alpha) and interleukin 1 (beta) in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol 2001;85:444-449.

  25. Houlihan JM, Biro PA, Harper HM. The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E y HLA-G. J Immunol 1995;154:5665-5674.

  26. Magatti M, de Munari S, Vertua E, Nassuato C, et al. Amniotic mesenchymal tissue cell inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant 2009;18:899-914.

  27. Kakishita K, Elwan MA, Nakao N, Itakura T, Sakurawaga N. Human Amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson´s disease: a potential source of donor for transplantation therapy. Exp Neurol 2000;165:27-34.

  28. Kakishita K, Nakao N, Sakurawaga N, Itakura T. Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res 2003;980:48-56.

  29. Kong XY, Cai Z, Pan L, Zhang L, et al. Transplantation of human amniotic cells exerts neuroprotection in MPTP-induced Parkinson disease mice. Brain Res 2008; 1205:108-115.

  30. Yang X, Xue S, Dong W, Kong Y. Therapeutic effect of human amniotic epithelial cell transplantation into the lateral ventricle of hemiparkinsonian rats. Chinese Medical Journal 2009;122:2449-2454.

  31. Sankar V, Muthusamy R. Role of human amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience 2003;118:1-17.

  32. Wu ZY, Hui GZ, Lu Y, Wu X, Guo LH. Transplantation of human amniotic epithelial cells improves hindlimb function in rats with spinal cord injury. Chin Med J (Engl) 2006;119:2101-2107.

  33. Liu Y, Wu J, Huang Q, Hou J, et al. Human Amniotic epithelial cells ameliorate behavioral dysfunction and reduce infarct size in the rat middle cerebral artery occlusion model. Shock 2008;29:603-611.

  34. Yu SJ, Soncini M, Kaneko Y, Hess DC, et al. Amnion a potent graft source for cell therapy in stroke: Cell Transplant 2009;18:111-118.

  35. Sakuragawa N, Enosawa S, Ishii T, Thangavel R, et al. Human amniotic epithelial cells are promising transgene carriers for allogeneic cell transplantation into liver. J Hum Genet 2000;45:171-176.

  36. Takahashi S, Ohsugi K, Yamamoto T, Shiomi M, Sakuragawa N. A novel approach to ex vivo gene therapy for familiar hypercholesterolemia using human amniotic epithelial cells as transgene carrier. Tohoku J Exp Med 2001;193:279-292.

  37. Takahashi N, Enosawa S, Mitani T, Lu H, et al. Transplantation of amniotic epithelial cells into fetal rat liver by in utero manipulation. Cell Transplant 2002; 11:443-449.

  38. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct 2004;29:73-83.

  39. Miki T, Marongiu F, Ellis EC, Dorko K, et al. Production of hepatocyte-like cells from human amnion. Methods Mol Biol 2009;481:1-14.

  40. Manuelpillai I, Tchongue J, Lourensz D, Vaghjiani V, et al. Transplantation of human amniotic epithelial cells reduce hepatic fibrosis in immunocompetent CCl4-treated mice. Cell Transplantation 2010;19:1157-1168.

  41. Zhao P, Ise H, Hongo M, Ota M, et al. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005;79:528-535.

  42. Ventura C, Cantoni S, Bianchi F, Lionetti V, et al. Hyaluronan mixed esters of butyric and retinoic acid drives cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infracted rat hearts. J Biol Chem 2007;282:14243-14252.

  43. Cargnoni A, Di Marcello M, Campagnol M, Nassuato C, et al. Amniotic membrane patching promotes ischemic rat heart repair. Cell Transplant 2009;18:1147-1159.

  44. Wei JP, Zhang TS, Kawa S, Aizawa T, et al. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant 2003;12:545-552.

  45. Cargnoni A, Gibelli L, Tosini A, Signoroni PB, et al. Transplantation of allogenic and xenogenic placenta derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 2009;18:405-422

  46. Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, et al. Human amniotic epithelial cell transplantation abrogates lung fibrosis and augment repair. Am J Respi Crit Care Med 2010;182:643-651.

  47. Yuge I, Takumi Y, Koyabu K, Hashimoto S, et al. Transplanted human amniotic epithelial express connexin 26 y Na-K-ATPasa in the inner ear. Transplantation 2004;77:1452-1454.

  48. Xing L, Franz MG, Marcelo CL, Smith CA, et al. Amnion-derived multipotent progenitor cells increase gain of incisional breaking strength and decrease incidence and severity of acute wound failure. J Burns and Wounds 2007;7:39-52.

  49. Prather WR, Toren A, Meiron M, Ofir R, et al. The role of placental derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy 2009;11:427-434.

  50. Davis JW. Skin transplantation with a review of 550 cases at the John Hopkins Hospital. Johns Hopkins Med J 1910;15:307-396.

  51. Trefold JD, Trelford-Sauer M. The amnion in surgery, past and present. Am J Obstet Gynecol 1979;134:833-845.

  52. Ganatra MA. Amniotic membrane in surgery. J Pak Med Assoc 2003;53:29-32.

  53. De Rotth A. Plastic repair of conjunctival defects with fetal membranes. Arch Ophthalmol 1940;23(5):22-525.

  54. Sorby A, Symons HM. Amniotic membrane grafts in caustic burns of eye. Br J Ophthalmol 1946;30:337-345.

  55. Dua HS, Gomes JA, King AJ, Maharajan S. The Amniotic membrane in ophthalmology. Survey of Ophthalmology 2004;49:51-77.

  56. Gomes JA, Roman A, Santos MS, Dua HS. Amniotic membrane use in ophthalmology. Curr Opin Ophthalmol 2005;16:233-240.

  57. Baradaran-Raffi A, Aghayan HR, Arjmand B, Javadi MA. Amniotic membrane transplantation. Iranian J Ophthalmolol Res 2007;2:58-73.

  58. Kim JC y Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995;14: 473-484.

  59. Zemba M, Andrei S, Cucu B, Bratulescu M, et al. Amniotic Membrane transplantation in palliative treatment of bullous keratopathy. Oftalmologia 2006;50:51-53.

  60. Habot-Wilner Z, Spierer A, Barequet IS, Greenbaum A. Use of amniotic membrane graft and corneal transplantation in a patient with bilateral keratomalacia induced by uncontrolled phenylketonuria. Cornea 2007;26:629-631.

  61. Motolese J, Mazzera L, Frezzotti P, Motolese PA, Motolese E. Use of amniotic membrane transplantation in isolated conjunctival Bowen disease: a case report. Eur J Ophthalmol 2010; 20:604-607.

  62. Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 2000;343:86-93.

  63. Altan-Yaycioglu R, Akova YA, Oto S. Amniotic membrane transplantation for treatment of symblepharon in a patient with recessive dystrophic epidermolysis bullosa. Cornea 2006; 25:971-973.

  64. Fernandes M, Sridhar MS, Sangwan VS, Rao GN. Amniotic membrane transplantation for ocular surface reconstruction. Cornea 2005;24:643-653.

  65. Ha HS, Song KY, Kim JC. Ultrastructural analysis of in vivo expanded corneal epithelium on amniotic membrane. J Korean Med Sci 2006;21:544-549.

  66. Nubile M, Dua HS, Evb-M Lanzini T, Carpineto P, et al. Amniotic membrane transplantation for the management of corneal epithelial defects: an in vivo confocal microscopic study. Br J Ophthalmol 2008;92:54-60.

  67. Dekaris I, Mravicic I, Barisic A, Draca N, Pauk M. Amniotic membrane transplantation in the treatment of persistent epithelial defect on the corneal graft. Cell Antropol 2010;34 Suppl 2:15-19.

  68. Muraine M, Descargues G, Franck O, Villeroy F, et al. Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases. J Fr Ophtalmol 2001;24:798-812.

  69. Sangwan VS, Vemuganti GK, Singh S, Balasubramanian D. Successful reconstruction of damaged ocular outer surface in humans using limbal and conjunctival stem cell culture methods. Biosci Rep 2003;23:169-174.

  70. Sangwan VS, Matalia HP, Vemuganti GK, Fatima A, et al. Clinical outcome of autologous cultivated limbal epithelium transplantation. Indian J Ophthalmol 2006; 54:29-34.

  71. Mermet I, Pottier N, Sainthillier JM, Malugani C, et al. Use of amniotic membrane transplantation in the treatment of venous leg ulcers. Wound Repair Regen 2007;15: 459-464.

  72. Hasegawa T, Mizoguchi M, Haruna K, Mizuno Y, et al. Amnia for intractable skin ulcers with recessive dystrophic epidermolysis bullosa: report of three cases. J Dermatol 2007;34:328-332.

  73. Bujang-Safawi E, Halim AS, Khoo TL, Dorai AA. Dried irradiated human amniotic membrane as a biological dressing for facial burns--a 7-year case series. Burns 2010;36: 876-882.

  74. Insausti CL, Alcaráz A, García-Vizcaíno EM, Mrowiec A, et al. Amniotic membrane induces epithelialization in massive posttraumatic wounds. Wound Rep Reg 2010;18:368-377.

  75. Brooke G, Rosstti T, Pelekanos R, Ilic N, et al. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials. British J Haematol 2009;144:571-579.




2020     |     www.medigraphic.com